<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>socioeconomic burden &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/socioeconomic-burden/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 18 Oct 2026 19:26:06 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>socioeconomic burden &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Bulgaria Faces Soaring €1.39 Billion Burden from Age-Related Macular Degeneration and Diabetic Macular Edema</title>
		<link>https://bioengineer.org/bulgaria-faces-soaring-e1-39-billion-burden-from-age-related-macular-degeneration-and-diabetic-macular-edema/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sun, 18 Oct 2026 19:26:06 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Age-related macular degeneration]]></category>
		<category><![CDATA[Anti-VEGF Therapy]]></category>
		<category><![CDATA[Bulgaria]]></category>
		<category><![CDATA[cost of illness]]></category>
		<category><![CDATA[diabetic macular edema]]></category>
		<category><![CDATA[diabetic retinopathy]]></category>
		<category><![CDATA[disability-adjusted life years]]></category>
		<category><![CDATA[eye care policy]]></category>
		<category><![CDATA[health economics]]></category>
		<category><![CDATA[screening]]></category>
		<category><![CDATA[socioeconomic burden]]></category>
		<category><![CDATA[vision loss]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=435530</guid>

					<description><![CDATA[New cost-of-illness analyses reveal that age-related macular degeneration and diabetic macular edema cost Bulgaria €545.7 million between 2017 and 2023 and are projected to impose a €1.39 billion burden by 2032, driven largely by delayed diagnosis and well-being losses rather than direct medical care.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">435530</post-id>	</item>
	</channel>
</rss>
